215 related articles for article (PubMed ID: 22481922)
1. Regulatory T cells in human ovarian cancer.
Peng DJ; Liu R; Zou W
J Oncol; 2012; 2012():345164. PubMed ID: 22481922
[TBL] [Abstract][Full Text] [Related]
2. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
Roncarolo MG; Gregori S; Levings M
Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
[TBL] [Abstract][Full Text] [Related]
3. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
Curiel TJ; Coukos G; Zou L; Alvarez X; Cheng P; Mottram P; Evdemon-Hogan M; Conejo-Garcia JR; Zhang L; Burow M; Zhu Y; Wei S; Kryczek I; Daniel B; Gordon A; Myers L; Lackner A; Disis ML; Knutson KL; Chen L; Zou W
Nat Med; 2004 Sep; 10(9):942-9. PubMed ID: 15322536
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.
Cai SF; Cao X; Hassan A; Fehniger TA; Ley TJ
Blood; 2010 Mar; 115(9):1669-77. PubMed ID: 19965675
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis.
Haas J; Fritzsching B; Trübswetter P; Korporal M; Milkova L; Fritz B; Vobis D; Krammer PH; Suri-Payer E; Wildemann B
J Immunol; 2007 Jul; 179(2):1322-30. PubMed ID: 17617625
[TBL] [Abstract][Full Text] [Related]
6. FOXP3+ regulatory T cells in the human immune system.
Sakaguchi S; Miyara M; Costantino CM; Hafler DA
Nat Rev Immunol; 2010 Jul; 10(7):490-500. PubMed ID: 20559327
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
8. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.
Lin YC; Mahalingam J; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Chiu CT; Lin CY
Int J Cancer; 2013 Mar; 132(6):1341-50. PubMed ID: 22907255
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells and inhibitory cytokines in autoimmunity.
Bettini M; Vignali DA
Curr Opin Immunol; 2009 Dec; 21(6):612-8. PubMed ID: 19854631
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression.
Peterson RA
Toxicol Pathol; 2012; 40(2):186-204. PubMed ID: 22222887
[TBL] [Abstract][Full Text] [Related]
11. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner.
Andersson J; Tran DQ; Pesu M; Davidson TS; Ramsey H; O'Shea JJ; Shevach EM
J Exp Med; 2008 Sep; 205(9):1975-81. PubMed ID: 18710931
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance.
Chaturvedi V; Collison LW; Guy CS; Workman CJ; Vignali DA
J Immunol; 2011 Jun; 186(12):6661-6. PubMed ID: 21576509
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
Collison LW; Workman CJ; Kuo TT; Boyd K; Wang Y; Vignali KM; Cross R; Sehy D; Blumberg RS; Vignali DA
Nature; 2007 Nov; 450(7169):566-9. PubMed ID: 18033300
[TBL] [Abstract][Full Text] [Related]
14. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.
Korporal M; Haas J; Balint B; Fritzsching B; Schwarz A; Moeller S; Fritz B; Suri-Payer E; Wildemann B
Arch Neurol; 2008 Nov; 65(11):1434-9. PubMed ID: 19001161
[TBL] [Abstract][Full Text] [Related]
15. T regulatory cells in allergy and health: a question of allergen specificity and balance.
Taylor A; Verhagen J; Akdis CA; Akdis M
Int Arch Allergy Immunol; 2004 Sep; 135(1):73-82. PubMed ID: 15340251
[TBL] [Abstract][Full Text] [Related]
16. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
[TBL] [Abstract][Full Text] [Related]
17. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
Liu T; Soong L; Liu G; König R; Chopra AK
Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
[TBL] [Abstract][Full Text] [Related]
18. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice.
Masteller EL; Warner MR; Tang Q; Tarbell KV; McDevitt H; Bluestone JA
J Immunol; 2005 Sep; 175(5):3053-9. PubMed ID: 16116193
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.
Yadav M; Louvet C; Davini D; Gardner JM; Martinez-Llordella M; Bailey-Bucktrout S; Anthony BA; Sverdrup FM; Head R; Kuster DJ; Ruminski P; Weiss D; Von Schack D; Bluestone JA
J Exp Med; 2012 Sep; 209(10):1713-22, S1-19. PubMed ID: 22966003
[TBL] [Abstract][Full Text] [Related]
20. Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.
Dasgupta G; Chentoufi AA; You S; Falatoonzadeh P; Urbano LA; Akhtarmalik A; Nguyen K; Ablabutyan L; Nesburn AB; BenMohamed L
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3321-33. PubMed ID: 21273544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
